Data integration, analysis, and interpretation of eight academic CLARITY-BPA studies

Archive ouverte

Heindel, Jerrold J. | Belcher, Scott, M. | Flaws, Jodi A. | Prins, Gail S. | Ho, Shuk-Mei | Mao, Jiude | Patisaul, Heather B. | Ricke, William | Rosenfeld, Cheryl S. | Soto, Ana M. | Vom Saal, Frederick S. | Zoellerk, R. Thomas

Edité par CCSD ; Elsevier -

SCHOLARLY ARTICLEData integration, analysis, and interpretation of eight academic CLARITY-BPA studies1 Dec 2020Reproductive Toxicology98:29-60Co-authors Heindel JJ, Belcher S, Flaws JA, Prins GS, Ho SM...View PDF10.1016/j.reprotox.2020.05.014. International audience. “Consortium Linking Academic and Regulatory Insights on BPA Toxicity” (CLARITY-BPA) was a comprehensive “industry-standard” Good Laboratory Practice (GLP)-compliant 2-year chronic exposure study of bisphenol A (BPA) toxicity that was supplemented by hypothesis-driven independent investigator-initiated studies. The investigator-initiated studies were focused on integrating disease-associated, molecular, and physiological endpoints previously found by academic scientists into an industry standard guideline-compliant toxicity study. Thus, the goal of this collaboration was to provide a more comprehensive dataset upon which to base safety standards and to determine whether industry-standard tests are as sensitive and predictive as molecular and disease-associated endpoints. The goal of this report is to integrate the findings from the investigator-initiated studies into a comprehensive overview of the observed impacts of BPA across the multiple organs and systems analyzed. For each organ system, we provide the rationale for the study, an overview of methodology, and summarize major findings. We then compare the results of the CLARITY-BPA studies across organ systems with the results of previous peer-reviewed studies from independent labs. Finally, we discuss potential influences that contributed to differences between studies. Developmental exposure to BPA can lead to adverse effects in multiple organs systems, including the brain, prostate gland, urinary tract, ovary, mammary gland, and heart. As published previously, many effects were at the lowest dose tested, 2.5μg/kg /day, and many of the responses were non-monotonic. Because the low dose of BPA affected endpoints in the same animals across organs evaluated in different labs, we conclude that these are biologically – and toxicologically – relevant.

Consulter en ligne

Suggestions

Du même auteur

Data integration, analysis, and interpretation of eight academic CLARITY-BPA studies

Archive ouverte | Heindel, Jerrold, J | CCSD

International audience. Consortium Linking Academic and Regulatory Insights on BPA Toxicity" (CLARITY-BPA) was a comprehensive "industry-standard" Good Laboratory Practice (GLP)-compliant 2-year chronic exposure stu...

Estimating Burden and Disease Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union

Archive ouverte | Trasande, Leonardo | CCSD

International audience. Context:Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability.Objective:The objective was to quantify a rang...

Minireview: Endocrine Disruptors: Past Lessons and Future Directions

Archive ouverte | Schug, Thaddeus, T | CCSD

International audience. Within the past few decades, the concept of endocrine-disrupting chemicals (EDCs) has risen from a position of total obscurity to become a focus of dialogue, debate, and concern among scienti...

Chargement des enrichissements...